Image:
Tom Hopkins: "While the UK is a world leader in areas such as university R&D, it is competing against countries where the level of patient capital is that much greater."
It is vital that recent high-profile concerns over funds with illiquid holdings do not discourage policymakers and regulators from addressing the patient capital - and equity gap - problem in the UK, writes Tom Hopkins
The modern industrial strategy launched back in 2017 has put innovation - and, in particular, university spin-out research and development (R&D) - at the forefront of positioning the UK in the wake of...
To continue reading this article...
Join Professional Adviser
- Unlimited access to real-time news, industry insights and market intelligence.
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters.
- Make smart business decisions with the latest developments in regulation, investing retirement and protection.
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes.
